enVVeno Medical Corp is a late clinical-stage medical device company focused on advancing bioprosthetic (tissue-based) solutions to improve the standard of care for treating venous disease... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
NVNO is expected to report earnings to rise 21.74% to -28 cents per share on February 26
Q4'25
Est.
$-0.28
Q3'25
Beat
by $0.07
Q2'25
Missed
by $0.03
Q1'25
Beat
by $0.12
Q4'24
Est.
$-0.35
The last earnings report on November 12 showed earnings per share of -23 cents, beating the estimate of -30 cents. With 109.68K shares outstanding, the current market capitalization sits at 13.92M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. NVNO showed earnings on November 12, 2025. You can read more about the earnings report here.